Scientists Target Bowel Cancer DNA

0:00Sciences at the University of Edinburgh just kicked off a 1.5 million pound study funded by Cancer Research UK to take down bowel cancer. Cells The goal is to mess with their DNA messaging system, the trick that lets these cells hide from the immune system. By causing errors in that system, the team wants to make the cancer cells stand out so the body can spot and destroy them. The project zeroes in on a process called RNA splicing to sabotage those sneaky messages telling cancer to grow. This could make immunotherapy work better, turning invisible tumors into easy targets for the immune defenses. Around 85% of bowel cancer patients don't respond to immunotherapy right now, which is a huge gap. But experts like Project Leader Dr. Kevin Mayan see massive potential here, since this treatment can cure rather than just manage the disease with. Fewer side effects Rising cases in younger folks, especially women in Scotland and England, age 25-49, make

1:00this research even more urgent. Cancer Research UK is all in, with their director calling it innovative and game-changing. They stress how understanding why some patients respond, and others don't, could unlock better therapies using our own immune power. This push comes as bowel cancer claims 16,800 lives yearly in the UK, including 1,700 in Scotland. Keep an eye on these breakthroughs. They could redefine the fight against this killer. Stay in form with Edinburgh News Today, AI-powered updates.